Elizabeth Kornaga
Associate
Elizabeth Kornaga is a translational scientist, advisor, biostatistician, and quality and biosafety officer at the Tom Baker Cancer Centre Translational Labs in Calgary, Alberta. She is a Transformative Pathology Associate of OICR.
Current affiliations
- Translational Scientist, Tom Baker Cancer Centre
Research interests
- Clinical research
- Immunohistochemistry
- Molecular Pathology
- Diagnostic development
Select publications
- Ho CK, Kornaga EN, Klimowicz AC, …, Doll CM. Expression of DNA damage response proteins in cervical cancer patients treated with radical chemoradiotherapy. Gynecol Oncol. 2017; 145(1):176-184.
- Enwere EK, Kornaga EN, Dean M, …, Doll CM. Expression of PDL1 and presence of CD8-positive T cells in pre-treatment specimens of locally advanced cervical cancer. Mod Pathol. 2017; 30(4): 577-586.
- Arjumand W, Merry CD, Wang C, …, Kornaga E, …, Lees-Miller SP. Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells. Oncotarget. 2016;7(50):82424-82439.
- Kornaga EN, Klimowicz AC, Guggisberg N, …, Magliocco AM. Evaluation of three commercial progesterone receptor assays in a single tamoxifen-treated breast cancer cohort. Mod Pathol. 2016;29(12):1492-1500.
- Kornaga EN, Klimowicz AC, Guggisberg N, …, Magliocco AM. A systematic comparison of three commercial estrogen receptor assays in a single clinical outcome breast cancer cohort. Mod Pathol. 2016;29(8):799-809.
See Dr. Kornaga’s recent publications on PubMed.
Awards
- Alberta Graduate Student Scholarship, 2005
Previous experience
- MSc, University of Calgary
- BSc, McGill University
Opportunities to collaborate
To collaborate with Elizabeth Kornaga, please contact her directly.
Visit OICR’s Collaborative Research Resources directory for more opportunities to collaborate with OICR researchers.
Related links
University of Calgary Cumming School of Medicine Faculty Page – Elizabeth Kornaga
Contact
Elizabeth Kornaga
Elizabeth.Kornaga@ahs.ca
